MARÍA DOLORES
CABALLERO BARRIGÓN
Ikertzailea 1998-2022 tartean
UCLA Medical Center
Santa Mónica, Estados UnidosUCLA Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2018
-
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204
2014
-
Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: Pivotal study update demonstrates durable responses
Journal of Hematology and Oncology, Vol. 7, Núm. 1